Biochemical Markers of Oxidative and Nitrosative Stress in Acne Vulgaris: Correlation With Disease Activity

Journal of Clinical Laboratory Analysis

Volumn 27, Issue 1, 2013, Pages 45-52

  Al Shobaili, Hani A ^a   Alzolibani, Abdullateef A ^a   Al Robaee, Ahmad A ^a   Meki, Abdel Raheim M A ^a   Rasheed, Zafar ^a  

^a QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Acne vulgaris; Biomarkers; Lipid peroxidation; Nitration; Protein oxidation

Indexed keywords

BIOLOGICAL MARKER; CARBONYL DERIVATIVE; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ACNE VULGARIS; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; NITROSATIVE STRESS; OXIDATION; OXIDATIVE STRESS;

ACNE VULGARIS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; FEMALE; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; MALE; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; STATISTICS, NONPARAMETRIC; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 84872518213     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21560     Document Type: Article

References (41)

1. Sathish D, Shayeda, Rao YM. Acne and its treatment options - A review. Curr Drug Deliv 2011; 8:634-639.
2. Simpson RC, Grindlay DJ, Williams HC. What's new in acne? An analysis of systematic reviews and clinically significant trials published in 2010-11. Clin Exp Dermatol 2011;36:840-843.
3. Del Rosso JQ. Combination topical therapy in the treatment of acne. Cutis 2006;78:5-12.
4. Tabak O, Gelisgen R, Erman H, et al. Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin Invest Med 2011;34:E163-E171.
5. Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev 2000;32:307-326.
6. Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 2008;283:21837-21841.
7. Poon HF, Vaishnav RA, Gelchell TV, Getchell ML, Butterfield DA. Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice. Neurobiol Aging 2006;27:1010-1019.
8. Tabner BJ, Turnbull S, El-Agnaf O, Allsop D. Production of reaction oxygen species from aggregating proteins implicated in Alzheimer's disease. Parkinson's disease and other neurodegenerative disease. Curr Top Med Chem 2001;1:507-517.
9. Arutyunova EI, Danshina PV, Domnina LV, Pleten AP, Muronetz VI. Oxidation of glyceraldehydes-3-phosphate dehydrogenase enhances its binding to nucleic acids. Biochem Biophys Res Commun 2003;307:547-552.
10. Shacter E, Williams JA, Levine RL. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med 1995;18:815-821.
11. Chou C. Binding of rheumatoid and lupus synovial fluids and sera-derived human IgG rheumatoid factor to degalactosylated IgG. Arch Med Res 2002;33:541-544.
12. Januszewski AS, Alderson NL, Jenkins AJ, Thorpe SR, Baynes JW. Chemical modification of proteins during peroxidation of phospholipids. J Lipid Res 2005;46:1440-1449.
13. Prasad A, Pospišil P. Two-dimensional imaging of spontaneous ultra-weak photon emission from the human skin: Role of reactive oxygen species. J Biophotonics 2011;4:840-849.
14. Ikeno H, Tochio T, Tanaka H, Nakata S. Decrease in glutathione may be involved in pathogenesis of acne vulgaris. J Cosmet Dermatol 2011;10:240-244.
15. Sarici G, Cinar S, Armutcu F, Altinyazar C, Koca R, Tekin NS. Oxidative stress in acne vulgaris. J Eur Acad Dermatol Venereol 2010;24:763-767.
16. Arican O, Kurutas EB, Sasmaz S. Oxidative stress in patients with acne vulgaris. Mediators Inflamm 2005;2005:380-384.
17. Nishikawa T, Naruse K, Kobayashi Y, et al. Involvement of nitrosative stress in experimental periodontitis in diabetic rats. J Clin Periodontol 2012;39:342-349.
18. Rocha BS, Gago B, Pereira C, et al. Dietary nitrite in nitric oxide biology: A redox interplay with implications for pathophysiology and therapeutics. Curr Drug Targets 2011;12:1351-1363.
19. Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol 1997;36:416-418.
20. Levine RL, Williams J, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994;233:346-357.
21. Dalle-Dome I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;29:23-38.
22. Thayer WS. Serum lipid peroxides in rats treated chronically with adriamycin. Biochem Pharmacol 1984;33:2259-2263.
23. Ding AH, Nathan CF, Stuchr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediate from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988;141:2407-2412.
24. Dutta P, Seirafi J, Halpin D, Pinto J, Rivlin R. Acute ethanol exposure alters hepatic glutathione metabolism in riboflavin deficiency. Alcohol 1995;12:43-47.
25. Misra HP, Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-3175.
26. Lolis MS, Bowe WP, Shalita AR. Acne and systemic disease. Med Clin North Am 2009;93:1161-1181.
27. Johnson BA, Nunley JR. Use of systemic agents in the treatment of acne vulgaris. Am Fam Physician 2000;62:1823-1836.
28. Akamatsu H, Horio T. The possible role of reactive oxygen species generated by neutrophils in mediating acne inflammation. Dermatology 1998;196:82-85.
29. Basak PY, Gultekin F, Kilinc I, Delibas N. The effect of benzoyl peroxide and benzoyl peroxide/erythromycin combination on the antioxidative defense system in papulopustular acne. Eur J Dermatol 2002;12:53-57.
30. Rasheed Z, Al-Shobaili HA, Alzolibani AA, et al. Immunological functions of oxidized human immunoglobulin G in type 1 diabetes mellitus: Its potential role in diabetic smokers as a biomarker of elevated oxidative stress. Dis Markers 2011;31:47-54.
31. Al-Shobaili HA, Al Robaee AA, Alzolibani A, Khan MI, Rasheed Z. Hydroxyl radical modification of immunoglobulin g generated cross-reactive antibodies: Its potential role in systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord 2011;4:11-19.
32. Rasheed Z. Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: Biochemical and immunological studies. Clin Biochem 2008;41:663-669.
33. Vera-Ramirez L, Ramirez-Tortosa M, Perez-Lopez P, Granados-Principal S, Battino M, Quiles JL. Long-term effects of systemic cancer treatment on DNA oxidative damage: The potential for targeted therapies. Cancer Lett 2012;327:134-141.
34. Lee HP, Pancholi N, Esposito L, et al. Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity. PLoS One 2012;7:e28033.
35. Michel F, Bonnefont-Rousselot D, Mas E, Drai J, Thérond P. Biomarkers of lipid peroxidation: Analytical aspects. Ann Biol Clin (Paris) 2008;66:605-620.
36. Brito C, Naviliat M, Tiscornia AC, et al. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J Immunol 1999;162:3356-3366.
37. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992;89:3030-3034.
38. Oates JC, Christensen EF, Reilly CM, Self SE, Gilkeson GS. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: Correlation with disease activity. Proc Assoc Am Physicians 1999;111:611-621.
39. Valdivia A, Pérez-Alvarez S, Aroca-Aguilar JD, Ikuta I, Jordán J. Superoxide dismutases: A physiopharmacological update. J Physiol Biochem 2009;65:195-208.
40. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 2003;333:19-39.
41. Santangelo F, Witko-Sarsat V, Drueke T, Descamps-Latscha B. Restoring glutathione as a therapeutic strategy in chronic kidney disease. Nephrol Dial Transplant 2004;19:1951-1955.